CLU and pancreatic neoplasm: These findings suggest that clusterin expression in pancreatic cancer cells may confer a phenotype resistant to chemotherapeutic agents;the reduction in clusterin expression by AS clusterin ODN enhances the sensitivity of cytotoxic chemotherapy for pancreatic cancer.